Analysed JAGUAR HEALTH INC (JAGX:NASDAQ) News Sources
Jaguar Health Inc (JAGX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
11-04-2026
yahoo.com
Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
10-04-2026
yahoo.com
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
08-04-2026
yahoo.com
Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
02-04-2026
yahoo.com
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
18-03-2026
yahoo.com
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
16-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
11-03-2026
yahoo.com
What is the current price of JAGUAR HEALTH INC (JAGX:NASDAQ)?
The current price of JAGUAR HEALTH INC (JAGX:NASDAQ) is $0.369.
JAGUAR HEALTH INC (JAGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of JAGUAR HEALTH INC (JAGX:NASDAQ) since the previous trading day is $-0.01.
JAGUAR HEALTH INC (JAGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of JAGUAR HEALTH INC (JAGX:NASDAQ) since the previous trading day is -2.6385%.
What is the most recent average sentiment score for JAGUAR HEALTH INC (JAGX:NASDAQ)?
The most recent average sentiment score for JAGUAR HEALTH INC (JAGX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for JAGUAR HEALTH INC (JAGX:NASDAQ)?
The most recent sentiment for JAGUAR HEALTH INC (JAGX:NASDAQ) is .
SEC-8K** Filing Available For JAGUAR HEALTH INC (JAGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.